Role of Nitric Oxide in the Impact of Aging on Myocardial Remodeling

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Cardiovascular Diseases
Interventions
DRUG

L-NAME

nitric oxide synthase inhibitor 4mg/kg infusion over 30-60 minutes prior to PET imaging

DRUG

L-Arginine

aids in nitric oxide production

DRUG

Phenylephrine

alpha agonist; 10 μg/kg/min infusion during PET study

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Washington University School of Medicine

OTHER

NCT00603720 - Role of Nitric Oxide in the Impact of Aging on Myocardial Remodeling | Biotech Hunter | Biotech Hunter